Ab&B Bio-Tech Co., Ltd. JSHKEX: 2627

Voluntary announcement - IND approval by china CDE for mRNA mpox vaccine

· Issued by Ab&B Bio-Tech Co., Ltd. JS via HKEXnews

Filed with HKEX · · 2 pages · English

Summary by 6ix AI

Ab&B Bio-Tech Co., Ltd. JS has announced the approval of its mRNA mpox vaccine candidate by the China CDE, following prior approval from the U.S. FDA. This marks the first mRNA mpox vaccine candidate to receive IND approval from both regulatory bodies. The company emphasizes the vaccine's superior immunogenicity compared to existing options, particularly for immunocompromised individuals.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Ab&B Bio-Tech Co., Ltd. JS on 6ix

Later from Ab&B Bio-Tech Co., Ltd. JS

All Ab&B Bio-Tech Co., Ltd. JS news releases